Succinic anhydride → HCID 9880964, 화합물

반응식

[CH3:1][C:2]1[CH:6]=[C:5]([CH3:7])[NH:4][C:3]=1[CH:8]=[C:9]1[C:17]2[C:12](=[CH:13][CH:14]=[CH:15][CH:16]=2)[NH:11][C:10]1=[O:18].[C:19]1(=[O:25])[O:24][C:22](=[O:23])[CH2:21][CH2:20]1>>[CH3:1][C:2]1[CH:6]=[C:5]([CH3:7])[NH:4][C:3]=1/[CH:8]=[C:9]1\[C:10](=[O:18])[N:11]([C:19](=[O:25])[CH2:20][CH2:21][C:22]([OH:24])=[O:23])[C:12]2[C:17]\1=[CH:16][CH:15]=[CH:14][CH:13]=2

참가 물질

반응물 2

HCID 7922Succinic anhydride

HCID 123015Semaxinib

생성물 1

HCID 9880964HCID 9880964, 화합물

실험 절차

The title compound was prepared from 3-(3,5-dimethyl-1H-pyrrol-2-ylmethylidene)-1,3-dihydro-indol-2-one and succinic anhydride (modification of procedure used to prepare (3Z)-1-acetyl-3-[(3,5-dimethyl-4-1H-pyrrol-2-yl)-methylidene]-1,3-dihydro-2H-indol-2-one).

출처 및 근거

ORD 기록: ord-03b0b3ac0d3147d1a24dcc6107f37d2e
출처 데이터셋: uspto-grants-2006_09
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US07109185B2

반응 노트

불러오는 중…